Illinois Department of Healthcare and Family Services Drugs and Therapeutics Advisory Board met Oct. 5.
Here is the agenda provided by the board:
I. Call to Order
II. Roll Call
III. Announcements
IV. Agenda and Conflict of Interest Review
V. Approval of the Minutes
VI. Elections
VII. Public Comments
VIII. PDL Drug Appeals
a. None at this meeting
IX. New Drug Appeals
a. Perseris
b. Rinvoq
c. Skyrizi
X. Drug Class Review- Jen Phillips, PharmD clinical review (with discussion and vote)
a. GLP-1 Weight Loss Drugs
XI. New Drug Initial Review-Jen Phillips, PharmD clinical review(with discussion and vote)
a. Dificid
b. Austedo XR
c. Uzedy
d. Prevymis
e. Elevidys
f. Tadliiq
g. Vyjuvek
h. Abilify Asimtufi
XII. Future Agenda Preview -Sheri Dolan
• Class reviews 2024
XIII. Provider Requested Reviews-Sheri Dolan
a. None for this meeting
XIV. Department Update-Dr. Goyal
XV. Adjournment
https://hfs.illinois.gov/content/dam/soi/en/web/hfs/sitecollectiondocuments/dtadvisoryboardagenda10052023.pdf
Alerts Sign-up